The risk factors and clinical course of asthma with fixed airflow limitation

• Main Authors: Pothirat C., Chaiwong W., Liwsrisakun C., Bumroongkit C., Deesomchok A., Theerakittikul T., Limsukon A., Phetsuk N.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84983381979&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/41740
• Institution: Chiang Mai University

© 2016, Medical Association of Thailand. All rights reserved. Objective: To identify risk factors and clinical course of asthma with fixed airflow limitation. Material and Method: A retrospective case-control study of asthma patients was conducted over a 15-month period. Asthma with fixed airflow limitation patients were defined as chronic asthmatics who had both post-bronchodilator (BD) and on-treatment ratio of forced expiratory in first second (FEV 1 )/forced vital capacity (FVC) persistently less than 0.7, whereas usual chronic asthma patients had post-BD and/or on-treatment ratio of FEV 1 /FVC more than 0.7. Serial asthma control tests (ACT), medication used, exacerbations were assessed. The risk factors were analyzed using logistic regression. Clinical characteristics between groups were compared using Student’s t-test and Fisher’s exact test. Results: One hundred twenty from 142 eligible subjects were enrolled. They had asthma with fixed airflow limitation (n = 40) and usual chronic asthma (n = 80). Potential risk factors of asthma with fixed airflow limitation included early disease onset (age < 15 years) [(adjusted odd ratio (OR) = 3.9, 95% confidence interval (CI) 1.9-8.3)] with longer disease duration (adjusted OR = 8.4, 95% CI 4.6-15.4 for > 30 years). Asthma with fixed airflow limitation patients had lower ACT scores (p < 0.001), lower level of asthma control (p < 0.001), required more asthma medications (p = 0.002), and higher rates of hospitalization (p = 0.001) than usual chronic asthma. Conclusion: The potential risk factors of asthma with fixed airflow limitation were earlier disease onset and longer disease duration. They had poorer asthma control, more medications needed, and higher rates of exacerbation than usual chronic asthma.